It’s only expected to get worse…

U.S. officials are warning about the spread of the Zika virus days after the State of Florida’s Governor declared a state of emergency where nine people had been diagnosed.

The World Health Organization (WHO) called it nothing short of a global health emergency, “spreading explosively” through the Americas… with a potential to impact another three to four million more people by the end of the year…

Thirty-one people in the U.S. have been diagnosed already. The Health Department just confirmed three cases in Washington, D.C.

Another was found in Texas.

Spain has just confirmed a pregnant woman has been diagnosed with Zika, too – the first such case in Europe.

It’s even been linked to more than 4,000 cases of microphaly, where babies are born with incomplete brain development and smaller skulls. One case was found in Hawaii.

The Centers for Disease Control and Prevention (CDC) issued travel restrictions for pregnant women as a result.

And if the virus isn’t stopped, it could impact up to 22.7 million people in the United States, primarily in Southern California, South Texas and Florida, as the weather begins to warm.

It could also lead to issues with the 2016 Olympics set for Brazil.

While there is no vaccine or a cure for Zika virus, it hasn’t stopped investors from rushing into speculative stocks, including one just recently recommended by The Cheap Investor.

As the virus becomes top priority for global health agencies looking for a cure, related stocks could become some of the most sought-after stocks in the world.

The Most Attractive Investment of 2016 

As the story hits home, as headlines, and government officials blare it’s an emergency, people panic… creating monster opportunities for companies – and stocks -- found to meet an unmet medical need, such as the Zika virus.

All we have to do is look back at the SARS scare and Ebola for proof…

In 2014, the worst outbreak of Ebola on record killed thousands, causing waves of global panic… before being brought under control in 2015. But as it was happening, as the headlines spread fear, as patients were brought to the United States, related stocks soared…

Look at Arbutus Biopharma (ABUS), for example -- formerly Tekmira (TKMR). The stock ran well off $4.30 lows to more than $31 a share – a 621% move, as the news was disseminated, creating mass global panic.

Arbutus Biopharma (ABUS), for example -- formerly Tekmira (TKMR)

In 2003, issues of severe acute respiratory syndrome (SARS) were first reported in Asia. Over the next few months, it would spread to dozens of countries, including North and South America, Europe and Asia before being contained.

As it spread, as the fear percolated, stocks like Alpha Pro Tech (APT) ran well off low of 96 cents to more than $3.20 – a 233% move.

Or when bird flu broke out in Asia in 2013, stocks like Biocryst Pharmaceuticals (BCRX) soared as China’s FDA gave fast-track status to the company’s anti-influenza drug to “satisfy demand” based on the fact that the drug was “effective and provides an alternative to patients who cannot inhale or take drugs orally…”

Biocryst Pharmaceuticals (BCRX)

There’s a great deal of opportunity sitting right in front of you as the Zika story breaks out.

Most likely, the story isn’t going away any time soon, giving you good reason to buy related stocks now. The Cheap Investor just recommended a great investment idea in the latest issue.

If a company can help meet an unmet medical need in an effort to protect millions of people, we’re looking at a multi-billion dollar investment opportunity that cannot be ignored.

And it could create one of the greatest investment stories of 2016, as panic just begins to set in.

1 Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment